Approved as Nubeqa, Darolutamide is a medication used to treat prostate cancer. It works as an androgen receptor inhibitor, blocking the effects of male hormones like testosterone that fuel cancer growth. It’s typically prescribed for patients with non-metastatic castration-resistant prostate cancer, helping manage advanced stages of the disease.